Cardiovascular disease in women

Cardiovascular disease in women refers to the group of disorders affecting the heart and blood vessels that show different symptoms, risk factors, and outcomes in women compared to men. Cardiovascular diseases (CVD) are the leading cause of death among women worldwide, with variations in prevalence and mortality rates across different regions and populations. Understanding the unique aspects of cardiovascular disease in women is crucial for effective prevention, diagnosis, and treatment.

Epidemiology

Cardiovascular disease is the top cause of death for women globally, claiming millions of lives each year. Despite the common misconception that CVD is more prevalent among men, women are equally affected. However, women often experience different symptoms, are diagnosed at later stages, and have different outcomes compared to men.

Risk Factors

Several risk factors contribute to the development of cardiovascular disease in women. Some of these factors affect women more severely than men, including diabetes, mental stress, depression, smoking, menopause, and certain autoimmune diseases. Pregnancy-related complications such as gestational diabetes and preeclampsia also increase the risk of developing CVD later in life.

Symptoms

The symptoms of cardiovascular disease in women can differ from those in men. While chest pain is the most common symptom of a heart attack in both sexes, women are more likely to experience other symptoms such as shortness of breath, nausea/vomiting, and back or jaw pain. This difference in symptoms can lead to delays in seeking treatment and diagnosis.

Diagnosis

Diagnosis of cardiovascular disease in women can be challenging due to the atypical presentation of symptoms and the underrepresentation of women in clinical research studies. Healthcare providers may use a combination of medical history, physical examination, and diagnostic tests, including electrocardiograms (ECG), echocardiography, and stress tests, to diagnose CVD in women.

Treatment

Treatment for cardiovascular disease in women may include lifestyle changes, medication, and in some cases, surgery. It is essential for treatment plans to be tailored to the individual, taking into account the unique risk factors and presentation of the disease in women. Preventive strategies such as regular exercise, a healthy diet, and smoking cessation are also crucial.

Prevention

Preventive measures for cardiovascular disease in women include managing risk factors such as hypertension, high cholesterol, and diabetes, adopting a healthy lifestyle, and undergoing regular screenings for heart disease. Awareness and education about the unique aspects of cardiovascular disease in women are vital for early detection and prevention.

Research and Future Directions

There is an ongoing need for more research focused on cardiovascular disease in women to understand the gender-specific differences in its epidemiology, pathophysiology, and treatment outcomes. Increased representation of women in clinical trials and gender-specific analysis of research data are essential for advancing knowledge and improving cardiovascular health outcomes for women.

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy